Efficacy and Safety of Daratumumab, Lenalidomide and Dexamethasone Therapy in the First Relapse of Multiple Myeloma Patients – Real World Data from Hungary
Our findings support the use of D-Rd as an effective option for first relapse in MM patients. However, our survival data are inferior to the results of the pivotal studies targeting the same population.
Authors
- Szabolcs Kosztolányi
- László Váróczy (ORCID: https://orcid.org/0000-0002-2873-5581)
- Szilvia Lovas
- László Imre Pinczés (ORCID: https://orcid.org/0000-0003-0453-1709)
- Gergely Varga (ORCID: https://orcid.org/0000-0001-6875-056X)
- Piroska Pettendi
- Peter Rajnics
- Katalin Farkas
- Mark Plander
- Nora Obajed Al-Ali
- Gabor Mikala
Institutions
- Semmelweis University (HU)
- University of Debrecen (HU)
- Somogy Megyei Kaposi Mór Oktató Kórház (HU)
- University of Kaposvár (HU)
- Markusovszky Egyetemi Oktatókórház (HU)
- Szent Imre Egyetemi Oktatókórház (HU)
- University of Pecs (HU)
Publication Details
- Journal
- Journal of Hematology
- Published
- 2025-12-01
- DOI
- https://doi.org/10.14740/jh2142
- Citations
- 1
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.77